跳至主要内容
临床试验/JPRN-UMIN000000940
JPRN-UMIN000000940已完成3 期

Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease - Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease

Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease (RAISE) Study Group0 个研究点目标入组 392 人开始时间: 2008年1月27日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
392

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
ot applicable 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1. Patients without informed consent to participate in this study. 2. Patients with past histories of Kawasaki disease (recurrent cases). 3. Patients diagnosed on the ninth day of illness or later (the first illness day is defined as the day when the patient develops a fever). 4. Kawasaki disease patients with coronary lesions before starting treatment. 5. Kawasaki disease patients being afebrile before starting treatment. 6. Patients having received steroids (oral, intravenous, intramuscular, or subcutaneous) within a month. 7. Patients having received intravenous immune gamma-globulin infusion. 8. Patients with the following severe diseases: immunodeficiency, chromosomal anomalies, congenital heart diseases, metabolic diseases, nephritis, collagen diseases, etc. 9. Patients with the following active bacterial infections: sepsis, septic meningitis, peritonitis, bacterial pneumonia, etc.

研究者

发起方
Randomized controlled trial to Assess Immunoglobulin plus Steroid Efficacy for Kawasaki disease (RAISE) Study Group

相似试验